183 related articles for article (PubMed ID: 30226577)
1. Overexpression of SENP1 reduces the stemness capacity of osteosarcoma stem cells and increases their sensitivity to HSVtk/GCV.
Liu F; Li L; Li Y; Ma X; Bian X; Liu X; Wang G; Zhang D
Int J Oncol; 2018 Nov; 53(5):2010-2020. PubMed ID: 30226577
[TBL] [Abstract][Full Text] [Related]
2. Connexin 43 SUMOylation improves gap junction functions between liver cancer stem cells and enhances their sensitivity to HSVtk/GCV.
Shen Y; Li Y; Ma X; Wan Q; Jiang Z; Liu Y; Zhang D; Liu X; Wu W
Int J Oncol; 2018 Mar; 52(3):872-880. PubMed ID: 29393359
[TBL] [Abstract][Full Text] [Related]
3. Silencing Ubc9 expression suppresses osteosarcoma tumorigenesis and enhances chemosensitivity to HSV-TK/GCV by regulating connexin 43 SUMOylation.
Zhang D; Yu K; Yang Z; Li Y; Ma X; Bian X; Liu F; Li L; Liu X; Wu W
Int J Oncol; 2018 Sep; 53(3):1323-1331. PubMed ID: 29956745
[TBL] [Abstract][Full Text] [Related]
4. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer.
Tang Q; Zhang D; Wan M; Jin L
Cancer Biother Radiopharm; 2007 Dec; 22(6):755-61. PubMed ID: 18158766
[TBL] [Abstract][Full Text] [Related]
5. Combined antitumor gene therapy with herpes simplex virus-thymidine kinase and short hairpin RNA specific for mammalian target of rapamycin.
Woo HN; Lee WI; Kim JH; Ahn J; Han JH; Lim SY; Lee WW; Lee H
Int J Oncol; 2015 Dec; 47(6):2233-9. PubMed ID: 26459571
[TBL] [Abstract][Full Text] [Related]
6. Treatment of advanced CNS malignancies with the recombinant adenovirus H5.010RSVTK: a phase I trial.
Eck SL; Alavi JB; Alavi A; Davis A; Hackney D; Judy K; Mollman J; Phillips PC; Wheeldon EB; Wilson JM
Hum Gene Ther; 1996 Aug; 7(12):1465-82. PubMed ID: 8844206
[TBL] [Abstract][Full Text] [Related]
7. Recombinant AAV-mediated HSVtk gene transfer with direct intratumoral injections and Tet-On regulation for implanted human breast cancer.
Li ZB; Zeng ZJ; Chen Q; Luo SQ; Hu WX
BMC Cancer; 2006 Mar; 6():66. PubMed ID: 16539746
[TBL] [Abstract][Full Text] [Related]
8. Bystander-mediated regression of osteosarcoma via retroviral transfer of the herpes simplex virus thymidine kinase and human interleukin-2 genes.
Walling HW; Swarthout JT; Culver KW
Cancer Gene Ther; 2000 Feb; 7(2):187-96. PubMed ID: 10770626
[TBL] [Abstract][Full Text] [Related]
9. Suicide HSVtk gene delivery by neurotensin-polyplex nanoparticles via the bloodstream and GCV Treatment specifically inhibit the growth of human MDA-MB-231 triple negative breast cancer tumors xenografted in athymic mice.
Castillo-Rodríguez RA; Arango-Rodríguez ML; Escobedo L; Hernandez-Baltazar D; Gompel A; Forgez P; Martínez-Fong D
PLoS One; 2014; 9(5):e97151. PubMed ID: 24824754
[TBL] [Abstract][Full Text] [Related]
10. Ablation of tumor-derived stem cells transplanted to the central nervous system by genetic modification of embryonic stem cells with a suicide gene.
Jung J; Hackett NR; Pergolizzi RG; Pierre-Destine L; Krause A; Crystal RG
Hum Gene Ther; 2007 Dec; 18(12):1182-92. PubMed ID: 18021021
[TBL] [Abstract][Full Text] [Related]
11. Herpes simplex virus thymidine kinase/ganciclovir system in multicellular tumor spheroids.
Finocchiaro LM; Bumaschny VF; Karara AL; Fiszman GL; Casais CC; Glikin GC
Cancer Gene Ther; 2004 May; 11(5):333-45. PubMed ID: 15107812
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous and controllable activation of suicide gene expression driven by the stress-inducible grp78 promoter resulting in eradication of sizable human tumors.
Dong D; Dubeau L; Bading J; Nguyen K; Luna M; Yu H; Gazit-Bornstein G; Gordon EM; Gomer C; Hall FL; Gambhir SS; Lee AS
Hum Gene Ther; 2004 Jun; 15(6):553-61. PubMed ID: 15212714
[TBL] [Abstract][Full Text] [Related]
13. Long-circulating liposome-encapsulated ganciclovir enhances the efficacy of HSV-TK suicide gene therapy.
Kajiwara E; Kawano K; Hattori Y; Fukushima M; Hayashi K; Maitani Y
J Control Release; 2007 Jul; 120(1-2):104-10. PubMed ID: 17509714
[TBL] [Abstract][Full Text] [Related]
14. Retrovirus-mediated herpes simplex virus thymidine kinase gene transduction renders human thyroid carcinoma cell lines sensitive to ganciclovir and radiation in vitro and in vivo.
Nishihara E; Nagayama Y; Mawatari F; Tanaka K; Namba H; Niwa M; Yamashita S
Endocrinology; 1997 Nov; 138(11):4577-83. PubMed ID: 9348181
[TBL] [Abstract][Full Text] [Related]
15. Multitracer studies during gene therapy of hepatoma cells with herpes simplex virus thymidine kinase and ganciclovir.
Haberkorn U; Altmann A; Morr I; Germann C; Oberdorfer F; van Kaick G
J Nucl Med; 1997 Jul; 38(7):1048-54. PubMed ID: 9225789
[TBL] [Abstract][Full Text] [Related]
16. [Different susceptibility of cell lines to thymidine kinase/ganciclovir-mediated killing effect and the way of cell death].
Zhang L; Liu T; Cui Q; Gao J
Zhonghua Bing Li Xue Za Zhi; 2000 Feb; 29(1):34-8. PubMed ID: 11866890
[TBL] [Abstract][Full Text] [Related]
17. Tumor reduction in vivo after adenoviral mediated gene transfer of the herpes simplex virus thymidine kinase gene and ganciclovir treatment in human head and neck squamous cell carcinoma.
Goebel EA; Davidson BL; Graham SM; Kern JA
Otolaryngol Head Neck Surg; 1998 Oct; 119(4):331-6. PubMed ID: 9781985
[TBL] [Abstract][Full Text] [Related]
18. Treatment of rat experimental brain tumors by herpes simplex virus thymidine kinase gene-transduced allogeneic tumor cells and ganciclovir.
Namba H; Tagawa M; Miyagawa T; Iwadate Y; Sakiyama S
Cancer Gene Ther; 2000 Jun; 7(6):947-53. PubMed ID: 10880027
[TBL] [Abstract][Full Text] [Related]
19. Rat adenocarcinoma cell line infected with an adenovirus carrying a novel herpes-simplex virus-thymidine kinase suicide gene construct dies by apoptosis upon treatment with ganciclovir.
Chu QD; Sun L; Li J; Byrnes K; Chervenak D; DeBenedetti A; Mathis JM; Li BD
J Surg Res; 2007 Nov; 143(1):189-94. PubMed ID: 17950092
[TBL] [Abstract][Full Text] [Related]
20. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
